These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 10638596)
1. Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration. Kohlroser J; Mathai J; Reichheld J; Banner BF; Bonkovsky HL Am J Gastroenterol; 2000 Jan; 95(1):272-6. PubMed ID: 10638596 [TBL] [Abstract][Full Text] [Related]
2. Case of the month. Hepatic and renal failure in a patient taking troglitazone and metformin. Chaudhry MU; Simmons DL J Ark Med Soc; 2001 Jul; 98(1):16-9. PubMed ID: 11452755 [TBL] [Abstract][Full Text] [Related]
3. Avandia, a leading alternative for Rezulin patients, prescribed to more than 700,000 patients. Diabetes Technol Ther; 2000; 2(2):292. PubMed ID: 11469275 [No Abstract] [Full Text] [Related]
4. Troglitazone in type II diabetes mellitus. Sparano N; Seaton TL Pharmacotherapy; 1998; 18(3):539-48. PubMed ID: 9620105 [TBL] [Abstract][Full Text] [Related]
5. Diabetes drug Rezulin: take it, but take precautions. Health News; 1999 May; 5(6):7. PubMed ID: 10546576 [No Abstract] [Full Text] [Related]
6. Thiazolidinediones and liver toxicity. Scheen AJ Diabetes Metab; 2001 Jun; 27(3):305-13. PubMed ID: 11431595 [TBL] [Abstract][Full Text] [Related]
7. Troglitazone for non-insulin-dependent diabetes mellitus. Med Lett Drugs Ther; 1997 May; 39(1001):49-51. PubMed ID: 9164446 [No Abstract] [Full Text] [Related]
8. Subacute hepatic failure associated with a new antidiabetic agent, troglitazone: a case report with autopsy examination. Fukano M; Amano S; Sato J; Yamamoto K; Adachi H; Okabe H; Fujiyama Y; Bamba T Hum Pathol; 2000 Feb; 31(2):250-3. PubMed ID: 10685643 [TBL] [Abstract][Full Text] [Related]
11. Actos (pioglitazone HCL) provides a safe, effective alternative for patients formerly taking Rezulin. Diabetes Technol Ther; 2000; 2(2):290-1. PubMed ID: 11469274 [No Abstract] [Full Text] [Related]
12. Diabetes recall. Though Rezulin's withdrawal is a blow for some patients, there are ways to cope. Here's how. Gorman C Time; 2000 Apr; 155(13):94. PubMed ID: 11009709 [No Abstract] [Full Text] [Related]
13. Advisory panel hears contradictory evidence, backs keeping troglitazone on market. Miller JL Am J Health Syst Pharm; 1999 May; 56(9):840, 842. PubMed ID: 10344603 [No Abstract] [Full Text] [Related]
15. New labeling and use changes for Rezulin. Klonoff DC Diabetes Technol Ther; 1999; 1(3):350. PubMed ID: 11484719 [No Abstract] [Full Text] [Related]
16. Diabetes medicine update. Old dogs, new tricks. Nakamoto M Diabetes Self Manag; 2003; 20(1):14-5. PubMed ID: 12632553 [No Abstract] [Full Text] [Related]
17. FDA reviews troglitazone. Donnelly R Diabetes Obes Metab; 1999 Mar; 1(2):65-6. PubMed ID: 11220513 [No Abstract] [Full Text] [Related]
18. Update in endocrinology. Whitcomb RW Ann Intern Med; 1998 May; 128(10):871. PubMed ID: 9599203 [No Abstract] [Full Text] [Related]
20. Troglitazone: a new class of oral antihyperglycemic for the treatment of type II diabetes. Teter ML Nurse Pract; 1997 Jul; 22(7):119-21. PubMed ID: 9253019 [No Abstract] [Full Text] [Related] [Next] [New Search]